This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hypercholesterolemia or HIV Infections
and you are
over 19
years old
The phase for this study is not defined.
Show me locations

The purpose

This study involves comparing the effectiveness of treatments in HIV positive patients who may be predisposed to heart attack or stroke. The investigators will evaluate the effectiveness of two drugs, often prescribed by doctors to these patients, at lowering cholesterol and thereby making the patient less them less vulnerable to suffering a heart attack or stroke. The investigators believe that the addition of a second drug, from a different class of cholesterol lowering medications, will improve the outcome of the patients by lowering cholesterol.

Provided treatments

  • Drug: Ezetimibe
  • Drug: Rosuvastatin (standard care)
Tris trial is registered with FDA with number: NCT00908011. The sponsor of the trial is University of British Columbia and it is looking for 43 volunteers for the current phase.
Official trial title:
A Prospective, Randomized Study to Determine the Effect of Ezetimibe in Addition to Rosuvastatin on Lipids in Participants With the Hypercholesterolemia Associated With HIV Antiretroviral Therapy